Target N. V. Biotech, 10% Owner at Molecular Templates, Inc. (MTEM), bought 80,000 shares at $11.94 ($955K) on 2021-01-29, disclosed to the SEC on 2021-02-01.
Open-market purchase of $955k MTEM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| MGNX | BUY | 2023-01-23 | $795K | — | Filing → |
| MGNX | BUY | 2022-11-25 | $1.8M | — | Filing → |
| MTEM | BUY | 2022-05-18 | $236K | — | Filing → |